These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21088400)

  • 1. Low lymphocyte ratio as a novel prognostic factor in acute heart failure: results from the Pre-RELAX-AHF study.
    Milo-Cotter O; Teerlink JR; Metra M; Felker GM; Ponikowski P; Voors AA; Edwards C; Weatherley BD; Greenberg B; Filippatos G; Unemori E; Teichman SL; Cotter G
    Cardiology; 2010; 117(3):190-6. PubMed ID: 21088400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of the RELAXin in acute heart failure study.
    Ponikowski P; Metra M; Teerlink JR; Unemori E; Felker GM; Voors AA; Filippatos G; Greenberg B; Teichman SL; Severin T; Mueller-Velten G; Cotter G; Davison BA
    Am Heart J; 2012 Feb; 163(2):149-55.e1. PubMed ID: 22305830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Representativeness of RELAX-AHF clinical trial population in acute heart failure.
    Wang TS; Hellkamp AS; Patel CB; Ezekowitz JA; Fonarow GC; Hernandez AF
    Circ Cardiovasc Qual Outcomes; 2014 Mar; 7(2):259-68. PubMed ID: 24594552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early drop in systolic blood pressure and worsening renal function in acute heart failure: renal results of Pre-RELAX-AHF.
    Voors AA; Davison BA; Felker GM; Ponikowski P; Unemori E; Cotter G; Teerlink JR; Greenberg BH; Filippatos G; Teichman SL; Metra M;
    Eur J Heart Fail; 2011 Sep; 13(9):961-7. PubMed ID: 21622980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of leukocyte counts on admissions for acute heart failure--presentation and outcome--results from a community based registry.
    Milo-Cotter O; Felker GM; Uriel N; Kaluski E; Edwards C; Rund MM; Weatherley BD; Cotter G
    Int J Cardiol; 2011 Apr; 148(1):17-22. PubMed ID: 19932515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of the relative lymphocyte count to predict one-year mortality in patients with acute heart failure.
    Núñez J; Núñez E; Miñana G; Sanchis J; Bodí V; Rumiz E; Palau P; Olivares M; Merlos P; Bonanad C; Mainar L; Llàcer A
    Am J Cardiol; 2011 Apr; 107(7):1034-9. PubMed ID: 21296316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study.
    Felker GM; Teerlink JR; Butler J; Hernandez AF; Miller AB; Cotter G; Davison BA; Filippatos G; Greenberg BH; Ponikowski P; Voors AA; Hua TA; Severin TM; Unemori E; Metra M
    J Am Coll Cardiol; 2014 Oct; 64(15):1591-8. PubMed ID: 25301463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
    Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
    Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 15 (GDF-15) in patients admitted for acute heart failure: results from the RELAX-AHF study.
    Cotter G; Voors AA; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Milo O; Hua TA; Qian M; Severin TM; Teerlink JR; Metra M; Davison BA
    Eur J Heart Fail; 2015 Nov; 17(11):1133-43. PubMed ID: 26333529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of acid-base balance in an emergency setting in patients with acute heart failure.
    Shirakabe A; Hata N; Kobayashi N; Shinada T; Tomita K; Tsurumi M; Matsushita M; Okazaki H; Yamamoto Y; Yokoyama S; Asai K; Mizuno K
    J Cardiol; 2012 Oct; 60(4):288-94. PubMed ID: 22819039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF.
    Metra M; Ponikowski P; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Hua TA; Severin T; Unemori E; Voors AA; Teerlink JR
    Eur Heart J; 2013 Oct; 34(40):3128-36. PubMed ID: 23999454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid clinical assessment of patients with acute heart failure: first blood pressure and oxygen saturation--is that all we need?
    Milo-Cotter O; Cotter G; Kaluski E; Rund MM; Felker GM; Adams KF; O'Connor CM; Weatherley BD
    Cardiology; 2009; 114(1):75-82. PubMed ID: 19372679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU.
    Maggioni AP; López-Sendón J; Nielsen OW; Hallén J; Aalamian-Mattheis M; Wang Y; Ertl G
    Eur J Heart Fail; 2019 Mar; 21(3):322-333. PubMed ID: 30604559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure.
    Uthamalingam S; Patvardhan EA; Subramanian S; Ahmed W; Martin W; Daley M; Capodilupo R
    Am J Cardiol; 2011 Feb; 107(3):433-8. PubMed ID: 21257011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure.
    Siirilä-Waris K; Lassus J; Melin J; Peuhkurinen K; Nieminen MS; Harjola VP;
    Eur Heart J; 2006 Dec; 27(24):3011-7. PubMed ID: 17127708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF.
    Metra M; Davison BA; Gimpelewicz C; Carubelli V; Felker GM; Filippatos G; Greenberg BH; Hua TA; Liu Z; Pang PS; Ponikowski P; Severin TM; Voors AA; Wang Y; Cotter G; Teerlink JR
    Int J Cardiol; 2018 Feb; 253():91-96. PubMed ID: 29306479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early worsening heart failure in patients admitted with acute heart failure--a new outcome measure associated with long-term prognosis?
    Weatherley BD; Milo-Cotter O; Felker GM; Uriel N; Kaluski E; Vered Z; O'Connor CM; Adams KF; Cotter G
    Fundam Clin Pharmacol; 2009 Oct; 23(5):633-9. PubMed ID: 19656213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and prognostic implications of active cytomegalovirus infection in patients with acute heart failure.
    Núñez J; Chilet M; Sanchis J; Bodí V; Núñez E; Miñana G; Tormo N; Clari MA; Pellicer M; Chorro FJ; Llàcer A; Navarro D
    Clin Sci (Lond); 2010 Aug; 119(10):443-52. PubMed ID: 20575763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.